Vasculitis in the gastrointestinal tract

Best Practice and Research: Clinical Gastroenterology

Volumn 19, Issue 2 SPEC. ISS., 2005, Pages 215-233

  Morgan, Matthew D ^a   Savage, Caroline O S ^a  

^a Medical School   (United Kingdom)

Author keywords

Churg Strauss syndrome; Gastrointestinal tract; Kawasaki disease; Microscopic polyangiitis; Polyarteritis nodosa; Purpura, Schoenlein Henoch; Takayasu's arteritis; Vasculitis; Wegener's granulomatosis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLACTOID PURPURA; ANCA ASSOCIATED VASCULITIS; AORTA ARCH SYNDROME; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE SEVERITY; FATALITY; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE INFARCTION; INTESTINE NECROSIS; LONG TERM CARE; LOW DRUG DOSE; META ANALYSIS; MONOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMAPHERESIS; POLYARTERITIS NODOSA; REVIEW; SEPSIS; SYSTEMIC VASCULITIS;

EID: 17044426731     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2004.11.010     Document Type: Review

References (106)

1. J.C. Jennette R.J. Falk K. Andrassy et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 1994 187-192
2. W. Arend B. Michel D. Bloch et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis Arthritis Rheum 33 1990 1129-1134
3. S.L. Johnston R.J. Lock & M.M. Gompels Takayasu arteritis: A review J Clin Pathol 55 2001 481-486
4. A. Waern P. Andersson & A. Hemmingsson Takayasu's arteritis: A hospital-region based study on occurrence, treatment and prognosis Angiology 34 1983 311-320
5. S. Hall W. Barr J. Lie et al. Takayasu arteritis. A study of 32 North American patients Medicine (Baltimore) 64 1985 89-99
6. K. Ishikawa Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy J Am Coll Cardiol 12 1988 964-972
7. B. Sharma N. Siveski-Iliskovic & P. Singal Takayasu arteritis may be underdiagnosed in North America Can J Cardiol 11 1995 311-316
8. B. Sharma S. Jain S. Suri & F. Numano Diagnostic criteria for Takayasu arteritis Int J Cardiol 54 1996 S141-S147
9. K. Ishikawa Natural history and classification of occlusive thromboaortopathy (Takayasu's disease) Circulation 57 1978 27-35
10. E. Angeli A. Vanzulli M. Venturini et al. The role of radiology in the diagnosis and management of Takayasu's arteritis J Am Soc Nephrol 14 2001 514-524
11. W. Schmidt A. Nerenheim E. Seipelt et al. Diagnosis of early Takayasu arteritis with sonography Rheumatology (Oxford) 41 2002 496-502
12. J. Park Conventional and CT angiographic diagnosis of Takayasu arteritis Int J Cardiol 54 1996 S165-S171
13. J. Park J. Chung K. Lee et al. CT angiography of Takayasu arteritis: comparison with conventional angiography J Vasc Interv Radiol 8 1997 393-400
14. E. Tso S. Flamm R. White et al. Takayasu arteritis: Utility and limitations of magnetic resonance imaging in diagnosis and treatment Arthritis Rheum 46 2002 1634-1642
15. S. Jain S. Kumari N. Ganguly & B. Sharma Current status of Takayasu arteritis in India Int J Cardiol 54 1996 S111-S116
16. M. Meneghetti J. Vasquez D. Alvarado et al. Takayasu arteritis: usefulness of radiologic and angiographic studies Arch Inst Cardiol Mex 59 1989 405-414
17. J. Ruige C. Van Geet A. Nevelsteen & R. Verhaeghe A 16-year survey of Takayasu's arteritis in a tertiary Belgian center Int Angiol 22 2003 414-420
18. C. Turkoglu A. Memis S. Payzin et al. Takayasu arteritis in Turkey Int J Cardiol 54 1996 S135-S136
19. J. Park M. Han S. Kim et al. Takayasu arteritis: Angiographic findings and results of angioplasty Am J Roentgenol 153 1989 1069-1074
20. R. Subramanyan J. Joy & K. Balakrishnan Natural history of aortoarteritis (Takayasu's disease) Circulation 80 1989 429-437
21. J. Shelhamer D. Volkman J. Parrillo et al. Takayasu's arteritis and its therapy Ann Intern Med 103 1985 121-126
22. G. Hoffman R. Leavitt G. Kerr et al. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate Arthritis Rheum 37 1994 578-582
23. A. Valsakumar U. Valappil V. Jorapur et al. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis J Rheumatol 30 2003 1793-1798
24. E. Daina A. Schieppati & G. Remuzzi Mycophenolate mofetil for the treatment of Takayasu arteritis: Report of three cases Ann Intern Med 130 1999 422-426
25. T. Miyata O. Sato H. Koyama et al. Long-term survival after surgical treatment of patients with Takayasu's arteritis Circulation 108 2003 1474-1480
26. P. Liang M. Tan-Ong & G. Hoffman Takayasu's arteritis: Vascular interventions and outcomes J Rheumatol 31 2004 102-106
27. K. Talwar R. Vasan S. Sharma et al. Non-specific aortoarteritis: long-term follow-up on immunosuppressive therapy Int J Cardiol 39 1993 79-84
28. R.W. Lightfoot Jr B.A. Michel D.A. Bloch et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa Arthritis Rheum 33 1990 1088-1093
29. A. Mahr L. Guillevin M. Poissonnet & S. Aymé Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: A capture-recapture estimate Arthritis Rheum 51 2004 92-99
30. R. Watts S. Lane G. Bentham & D. Scott Epidemiology of systemic vasculitis. A ten-year study in the United Kingdom Arthritis Rheum 43 2000 414-419
31. J.H. Stone Polyarteritis nodosa JAMA 288 2002 1632-1639
32. M.A. González-Gay & C. García-Porrúa Systemic vasculitis in adults in Northwestern Spain, 1988-1997: Clinical and epidemiologic aspects Medicine (Baltimore) 78 1999 292-308
33. B.J. McMahon W.L. Heyward D.W. Templin et al. Hepatitis B-associated polyarteritis nodosa in Alaskan eskimos: Clinical and epidemiologic features and long-term follow-up Hepatology 9 1989 97-101
34. M. Gayraud L. Guillevin P. le Toumelin et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Analysis of four prospective trials including 278 patients Arthritis Rheum 44 2001 666-675
35. C. Trepo & L. Guillevin Polyarteritis nodosa and extrahepatic manifestations of HBV infection: The case against autoimmune intervention in pathogenesis J Autoimmun 16 2001 269-274
36. G.S. Kirkland J. Savige D. Wilson et al. Classical polyarteritis nodosa and microscopic polyarteritis with medium vessel involvement - a comparison of the clinical and laboratory features Clin Nephrol 47 1997 176-180
37. L. Guillevin F. Lhote J. Amouroux et al. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: Indications for the classification of vasculitides of the polyarteritis Nodosa Group Br J Rheumatol 35 1996 958-964
38. S.M. Levine D.B. Hellmann & J.H. Stone Gastrointestinal involvement in polyarteritis nodosa (1986-2000): Presentation and outcomes in 24 patients Am J Med 112 2002 386-391
39. D. Adu A. Pall R. Luqmani et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis QJM 90 1997 401-409
40. K. El-Reshaid M. Kapoor W. El-Reshaid et al. The spectrum of renal disease associated with microscopic polyangiitis and classic polyarteritis nodosa in Kuwait Nephrol Dial Transplant 12 1997 1874-1882
41. A. Bakkaloglu S. Ozen E. Baskin et al. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa Arch Dis Child 85 2001 427-430
42. C.A. Langford Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: Where do we stand? Arthritis Rheum 44 2001 508-512
43. C. Agard L. Mahr A. Mahr & L. Guillevin Microscopic polyangiitis and polyarteritis nodosa: How and when do they start? Arthritis Rheum 49 2003 709-715
44. L. Guillevin F. Lhote P. Cohen et al. Polyarteritis nodosa related to hepatitis b virus: A prospective study with long-term observation of 41 patients Medicine (Baltimore) 74 1995 238-253
45. L. Mouthon P. Le Toumelin M. Andre et al. Polyarteritis nodosa and Churg-Strauss angiitis characteristics and outcome in 38 patients over 65 years Medicine (Baltimore) 81 2002 27-40
46. H.K. Ha S.H. Lee S.E. Rha et al. Radiologic features of vasculitis involving the gastrointestinal tract Radiographics 20 2000 779-794
47. L. Guillevin F. Lhote M. Gayraud et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: A prospective study in 342 patients Medicine (Baltimore) 75 1996 17-28
48. P. Frohnert & S. Sheps Long-term follow-up study of polyarteritis nodosa Am J Med 48 1967 8-14
49. M. Gayraud L. Guillevin P. Cohen et al. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: Comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for vasculitides Rheumatology (Oxford) 36 1997 1290-1297
50. L. Guillevin P. Cohen A. Mahr et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients Arthritis Rheum 49 2003 93-100
51. R.C. Holman A.T. Curns E.D. Belay et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000 Pediatrics 112 2003 495-501
52. R-K.R. Chang The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997 Pediatrics 111 2003 1124-1125
53. S. Bhatnagar G. Paul R. Subramanian et al. Kawasaki disease in Oman - a clinical study J Trop Pediatr 49 2003 361-366
54. S. Hayasaka Y. Nakamura M. Yashiro et al. Analyses of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years J Epidemiol 13 2003 246-250
55. K. Lee J. Han H. Lee et al. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000) Pediatr Infect Dis J 23 2004 52-55
56. M. Lynch R. Holman A. Mulligan et al. Kawasaki syndrome hospitalizations in Ireland, 1996 through 2000 Pediatr Infect Dis J 22 2003 959-963
57. R. Sittiwangkul Y. Pongprot W. Thongsongkrit et al. Kawasaki disease in Thai infants compared with older children Ann Trop Paediatr 24 2004 59-63
58. P.A. Brogan A. Bose D. Burgner et al. Kawasaki disease: An evidence based approach to diagnosis, treatment, and proposals for future research Arch Dis Child 86 2002 286-290
59. F. Falcini R. Cimaz G. Calabri et al. Kawasaki's disease in northern Italy: A multicenter retrospective study of 250 patients Clin Exp Rheumatol 20 2002 421-426
60. F. Zulian F. Falcini L. Zancan et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease J Pediatr 142 2003 731-735
61. T. Miyake J. Kawamori T. Yoshida et al. Small bowel pseudo-obstruction in Kawasaki disease Pediatr Radiol 17 1987 383-386
62. A. Malik Kawasaki disease in Malaysia Ann Trop Paediatr 16 1996 213-220
63. K. Barron D.J. Murphy E. Silverman et al. Treatment of Kawasaki syndrome: A comparison of two dosage regimens of intravenously administered immune globulin J Pediatr 117 1990 638-644
64. M. Engle N. Fatica J. Bussel et al. Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Preliminary report Am J Dis Child 143 1989 1300-1304
65. J. Newburger M. Takahashi A. Beiser et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 324 1991 1633-1639
66. K. Hashino M. Ishii M. Iemura et al. Re-treatment for immune globulin-resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy Pediatr Int 43 2001 211-217
67. J. Weiss B. Eberhard D. Chowdhury & B. Gottlieb Infliximab as a novel therapy for refractory Kawasaki disease J Rheumatol 31 2004 808-810
68. T. Mele & M. Evans Intestinal obstruction as a complication of Kawasaki disease J Pediatr Surg 31 1996 985-986
69. A. Rai C. Nast & S. Adler Henoch-Schonlein Purpura nephritis J Am Soc Nephrol 10 1999 2637-2644
70. J. Mills B. Michel D. Bloch et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura Arthritis Rheum 33 1990 1114-1121
71. M. Stewart J. Savage B. Bell & B. McCord Long term renal prognosis of Henoch-Schonlein purpura in an unselected childhood population Eur J Pediatr 147 1988 113-115
72. H. Nielsen Epidemiology of Schonlein-Henoch purpura Acta Paediatr Scand 77 1988 125-131
73. J.M. Gardner-Medwin P. Dolezalova C. Cummins & T.R. Southwood Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins Lancet 360 2002 1197-1202
74. G. Haugeberg R. Bie A. Bendvold et al. Primary vasculitis in a Norwegian community hospital: A retrospective study Clin Rheumatol 17 1998 364-368
75. S.E. Lane D.G.I. Scott A. Heaton & R.A. Watts Primary renal vasculitis in Norfolk - increasing incidence or increasing recognition? Nephrol Dial Transplant 15 2000 23-27
76. C. Garcia-Porrua & M. Gonzalez-Gay Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch-Schonlein purpura in adults Semin Arthritis Rheum 28 1999 404-412
77. M. Calvino J. Llorca C. Garcia-Porrua et al. Henoch-Schonlein purpura in children from northwestern Spain: A 20-year epidemiologic and clinical study Medicine (Baltimore) 80 2001 279-290
78. S. Katz M. Borst I. Seekri & J. Grosfeld Surgical evaluation of Henoch-Schonlein purpura. Experience with 110 children Arch Surg 126 1991 849-853
79. A. Huber J. King & P. McLaine A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura BMC Med [electronic resource] 2 2004 7
80. B. Siskind M. Burrell H. Pun et al. CT demonstration of gastrointestinal involvement in Henoch-Schonlein syndrome Gastrointest Radiol 10 1985 352-354
81. R. Blanco V. Martinez-Taboada V. Rodriguez-Valverde et al. Henoch-Schonlein purpura in adulthood and childhood: Two different expressions of the same syndrome Arthritis Rheum 40 1997 859-864
82. G. Di Febo G. Gizzi G. Biasco & M. Miglioli Colonic involvement in adult patients with Henoch-Schoenlein purpura Endoscopy 16 1984 36-39
83. M. Esaki T. Matsumoto S. Nakamura et al. GI involvement in Henoch-Schonlein purpura Gastrointest Endosc 56 2002 920-923
84. S. Kato K. Ebina H. Naganuma et al. Intestinal IgA deposition in Henoch-Schonlein purpura with severe gastro-intestinal manifestations Eur J Pediatr 155 1996 91-95
85. H. Shepherd C. Patel J. Bamforth & P. Isaacson Upper gastrointestinal endoscopy in systemic vasculitis presenting as an acute abdomen Endoscopy 15 1983 307-311
86. K. Uchiyama N. Yoshida M. Mizobuchi et al. Mucosal IgA depositon in Henoch-Schönlein purpura with duodenal ulcer J Gastroenterol Hepatol 17 2002 728-729
87. E. Pillebout E. Thervet G. Hill et al. Henoch-Schonlein purpura in adults: Outcome and prognostic factors J Am Soc Nephrol 13 2002 1271-1278
88. D. Allen L. Diamond & D. Howell Anaphylactoid purpura in children (Schonlein-Henoch syndrome): Review with a follow-up of the renal complications Am J Dis Child 99 1960 833-854
89. N. Rosenblum & H. Winter Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura Pediatrics 79 1987 1018-1021
90. C. Glasier M. Siegel W. McAlister & G. Shackelford Henoch-Schonlein syndrome in children: Gastrointestinal manifestations Am J Roentgenol 136 1981 1081-1085
91. M. Gonzalez-Gay C. Garcia-Porrua J. Guerrero et al. The epidemiology of the primary systemic vasculitides in northwest Spain: Implications of the Chapel Hill Consensus Conference definitions Arthritis Rheum 49 2003 388-393
92. A. Masi H. GG L. JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis) Arthritis Rheum 33 1990 1094-1100
93. R. Leavitt F. AS B. DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis Arthritis Rheum 33 1990 1101-1107
94. U. Schonermarck P. Lamprecht E. Csernok & W.L. Gross Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA Rheumatology (Oxford) 40 2001 178-184
95. D. Bligny A. Mahr P. Toumelin et al. Predicting mortality in systemic Wegener's granulomatosis: A survival analysis based on 93 patients Arthritis Rheum 51 2004 83-91
96. G. Hoffman G. Kerr R. Leavitt et al. Wegener granulomatosis: An analysis of 158 patients Ann Intern Med 116 1992 488-498
97. K. Aasarod B.M. Iversen J. Hammerstrom et al. Wegener's granulomatosis: clinical course in 108 patients with renal involvement Nephrol Dial Transplant 15 2000 611-618
98. W. Koldingsnes & H. Nossent Predictors of organ damage and survival in Wegener's granulomatosis Rheumatology (Oxford) 41 2002 572-581
99. B. Storesund J. Gran & W. Koldingsnes Severe intestinal involvement in Wegener's granulomatosis: Report of two cases and review of the literature Rheumatology (Oxford) 37 1998 387-390
100. L. Guillevin J. Cordier F. Lhote et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis Arthritis Rheum 40 1997 2187-2198
101. M. Haubitz S. Schellong U. Gobel et al. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study Arthritis Rheum 41 1998 1835-1844
102. W. Koldingsnes J. Gran R. Omdal & G. Husby Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide Rheumatology (Oxford) 37 1998 659-664
103. C. Langford C. Talar-Williams K. Barron & M. Sneller A staged approach to the treatment of Wegener's granulomatosis: Induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance Arthritis Rheum 42 1999 2666-2673
104. J. Stone W. Tun & D. Hellman Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice J Rheumatol 26 1999 1134-1139
105. D. Jayne N. Rasmussen K. Andrassy et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 2003 36-44
106. I. Noth M.E. Strek & A.R. Leff Churg-Strauss syndrome Lancet 361 2003 587-594